Finally, some good news. This past October, amid efforts by the Trump administration aimed at improving drug price transparency, prices for some popular drugs dropped drastically.
According to the GoodRx Index, drug manufacturer Merck reduced the list price for Zepatier by 60% and six other drugs by around 10% each.
The GoodRx Index also showed the following trends during the month of October:
- Prescription fills spiked for popular quadrivalent flu shots like Fluzone and Fluarix. See More